Website & contact details
- Website
Pharmaspace (Aylesbury) Limited
- Incorporated
- 1 May 2014 (12 years)
- Industry
- Other human health activities (86900)
- Owned by
- Dean Russell GainsleyLaitwood Capital Ltd
- Accounts type
- Total exemption full
- Region
- South East
- Address
- 73 Southern RoadThameOX9 2ED
Filing status
- Accounts due
- 28 February 2027
- Last accounts
- 31 May 2025
- Conf. stmt due
- 14 March 2027
- Last conf. stmt
- 28 February 2026
Officers 4 active
Officer details are public data from the Companies House register.
Director · Appointed 5 September 2025
Also at Zoot Medical Services Ltd (proposed for strike-off), CG Partners Limited, Grow Group Limited · more companies
British
Born July 1979 (47)
British
Born January 1975 (51)
Director · Appointed 22 May 2024
British
Born February 1983 (43)
British
Born August 1972 (54)
Officer history (1 former)
5 September 2025
5 September 2025
22 May 2024
22 May 2024
1 May 2015
1 May 2014
Ownership 3 active
People and entities with significant control, from the Companies House PSC register
British
Born July 1979 (47)
Private Limited Company
Reg. no. 15806654
Laitwood Capital Ltd
Corporate entity · Notified 22 May 2024
Owns 25–50% of shares
Holds 25–50% of voting rights
Private Company Limited By Shares
Former controllers (2)
22 May 2024
22 May 2024
Group structure 15 shown
Ownership group derived from the Companies House PSC register
Chartwell Business Finance Limited Owns 25–50% of shares
Chartwell International Ltd Owns 75–100% of shares
Halo Corporate FX Ltd Has significant influence or control
Kadena Digital Limited Has significant influence or control
Laborious Ltd Has significant influence or control
Laborious.Ai Ltd Has significant influence or control
Logical Search & Select Ltd Has significant influence or control
Pharmaspace (Aylesbury) Limited This company Owns 25–50% of shares
Stampout Ltd Owns 25–50% of shares
ZRC 1 Topco Limited Has significant influence or control
ZRC Topco Limited Has significant influence or control
ZRC Bidco Ltd Has significant influence or control
Financials
Balance sheet as at 31 May 2025 · total exemption full accounts
- Net Assets
- (£60,248)
- Cash
- £8,497
- Employees
- 2
- Debt Ratio
- 130%
- Current Ratio
- 0.8x
Trend
Net Assets
Balance sheet detail
| 2025 | 2024 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Fixed Assets | £316 | £448 | £1,725 | £1,274 | £368 |
| Current Assets | £197,962 | £207,772 | £220,394 | £247,178 | £242,526 |
| Cash | £8,497 | £8,325 | £23,666 | ||
| Creditors (< 1 year) | £246,423 | £146,511 | £185,381 | £186,095 | £211,335 |
| Creditors (> 1 year) | £12,103 | £22,310 | £36,202 | £50,000 | |
| Net Current Assets | (£48,461) | £61,261 | £35,013 | £61,625 | £31,191 |
| Net Assets | (£60,248) | £39,399 | £536 | £12,899 | £31,559 |
| Shareholder Funds | (£60,248) | £39,399 | £536 | £12,899 | £31,559 |
What Pharmaspace say about themselves
“Welcome to myPharmacyspace, your online aesthetic pharmacy for all your medical aesthetics and pharmaceutical products. We supply the full range of botulinum toxins including Botox, dermal fillers and clinic consumables. A one-stop-shop for all your facial aesthetics and skin rejuvenation product…”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 31 May 2026 | Total exemption full accounts | 31 May 2025 | ||
| 8 April 2026 | Confirmation statement with updates | 28 February 2026 | ||
| 15 September 2025 | Notification of a person with significant control | |||
| 15 September 2025 | Notification of a person with significant control | |||
| 15 September 2025 | Appointment of a director |
Some other companies at this address
Other companies in this industry
Newcastle Upon Tyne
London
London
Birmingham
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →